Xylem Inc
XYL: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|wV | LOCK|&^p?# | LOCK|y$&G^< |
Xylem Earnings: Solid Organic Order Growth Across All Segments
Narrow-moat-rated Xylem ended 2024 on a solid note, as its full-year adjusted EPS of $4.27 beat our estimate by $0.04 and the FactSet consensus estimate by $0.05, sending shares up by over 5%. After rolling our model forward one year, we’ve raised our fair value estimate to $116 per share from $113, mostly due to time value of money.
